BT
BRIAN TSE
Registered · LDAActive
The past 12 months
Agencies contacted
Commerce, Dept of (DOC)HOUSE OF REPRESENTATIVESOffice of Management & Budget (OMB)SENATE
Specific issues
Policies that promote domestic pharmaceutical manufacturing.
Medical/Disease Research/Clinical Labs · 2026 Q2
Support for the manufacture of bulk pharmaceuticals.
Manufacturing · 2026 Q2
Support for hemostatic technology research and the manufacturing of hemostatic products.
Medical/Disease Research/Clinical Labs · 2026 Q2
Sources
This profile is built from the public record: filings in the U.S. Senate Lobbying Disclosure Act system. lda.senate.gov ↗
Recent filings4
2026 Q2BRIGHT PATH LABORATORIES, INC.
Q2lda.gov → 2026 Q1BRIGHT PATH LABORATORIES, INC.
Q1lda.gov →